Which excipient will you choose?

Published: 20-Oct-2022
Ingredients

The right carrier also helps you to carry through your objectives!

 

galenIQ is a highly effective filler-binder derived from beet sugar. It is easily manoeuvrable and adaptable to many kinds of formulations. It especially takes care that the API is delivered and accepted by all patient groups, simply thanks to being sweet.

Let’s talk about excipients at our booth at CPHI so we can make medicine taste better together. Our team of knowledgeable experts will be happy to let you in on our latest process advancements and developments in manufacturing with our sweet filler binder. It is our objective to make the pathway to cure sweeter.

Discover our videos and benefits on our website!

 

 

 

  • Companies:
  • Beneo
See more

You may also like

Manufacturing

Orodispersibles and minitablets: optimising patient compliance by improving the sensory properties with isomalt

Read more
Orally dispersible minitablets are a drug dosage form that can help to improve patient compliance among children and others who have difficulty swallowing traditional tablets. A study shows that direct compression grade isomalt (galenIQ 721), with its pleasant sensory properties, can be a good choice of filler-binder

Trending Articles

  1. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  2. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  3. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach
  4. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  5. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Orodispersibles and minitablets: optimising patient compliance by improving the sensory properties with isomalt

Orally dispersible minitablets are a drug dosage form that can help to improve patient compliance among children and others who have difficulty swallowing traditional tablets. A study shows that direct compression grade isomalt (galenIQ 721), with its pleasant sensory properties, can be a good choice of filler-binder
Manufacturing

Beneo launches galenIQ 721 excipient for sachet powders

For manufacturers, sachets are a way to formulate a product without the challenges of compressing a powder into a tablet
Ingredients

Boosting the taste, stability and shelf-life of probiotic supplements

To support the stability, formulation and viability of micro-organisms for a healthy gut, BENEO presents galenIQ 721 at the CPhI Festival of Pharma 2020
Ingredients

galenIQ makes sugar-free medicated high-boiled lozenges with a long shelf-life

BENEO’s sweet-tasting excipient galenIQ 900 provides both manufacturers and consumers alike with technological and physiological benefits
Ingredients

SugaPolish FSC solution accelerates production process

Combines the aesthetic of dragées with the efficiency of film coating
Manufacturing

BENEO-Palatinit introduces new filler/binder granulation agent at CPhI 2008

<p>BENEO-Palatinit GmbH is extending its galenIQ range of bulk excipients, tailor-made for oral solid dosage forms such as tablets, capsules, coatings, and high-boiled lozenges, with a new grade for granulation. galenIQ 801 is a high-solubility refined powder grade that extends the capability of the 800 Series to include formulation of tablets, sachets or dry powder syrups through granulation processes. </p>
Ingredients

FrieslandCampina Ingredients debuts consumer-driven concepts at Vitafoods Europe

The company will exhibit its omega-3 ingredient, as well as its active gut health solution
Subscribe now